1.
Germline deletions in the EPCAM gene as a cause of Lynch syndrome – literature review
Katarzyna
Tutlewska,
Jan
Lubinski,
Grzegorz
Kurzawski
Hereditary Cancer in Clinical Practice 2013, 11 :9 (12 August 2013)
Abstract | Full text | PDF | PubMed
2.
Psoriasis vulgaris and familial cancer risk- a population-based study
Romuald
Maleszka,
Katarzyna
Paszkowska-Szczur,
Ewa
Soczawa,
Magdalena
Boer,
Monika
Różewicka-Czabańska,
Joanna
Wiśniewska,
Aneta
Mirecka,
Lidia
Krysztoforska,
Zygmunt
Adamski,
Jan
Lubinski,
Tadeusz
Dębniak
Hereditary Cancer in Clinical Practice 2013, 11 :6 (28 June 2013)
Abstract | Full text | PDF | PubMed
3.
Systemic treatment for hereditary cancers: a 2012 update
Evgeny
N
Imyanitov,
Tomasz
Byrski
Hereditary Cancer in Clinical Practice 2013, 11 :2 (1 April 2013)
Abstract | Full text | PDF | PubMed
4.
Familial gastric cancer: detection of a hereditary cause helps to understand its etiology
Ingrid
P
Vogelaar,
Rachel
S
van der Post,
Tanya
M
Bisseling,
J Han
JM
van Krieken,
Marjolijn
JL
Ligtenberg,
Nicoline
Hoogerbrugge
Hereditary Cancer in Clinical Practice 2012, 10 :18 (12 December 2012)
Abstract | Full text | PDF | PubMed
5.
DNA and RNA analyses in detection of genetic predisposition to cancer
Grzegorz
Kurzawski,
Dagmara
Dymerska,
Pablo
Serrano-Fernández,
Joanna
Trubicka,
Bartłomiej
Masojć,
Anna
Jakubowska,
Rodney
J
Scott
Hereditary Cancer in Clinical Practice 2012, 10 :17 (4 December 2012)
Abstract | Full text | PDF | PubMed
6.
Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent:
a case-control study
LaCreis
R
Kidd,
Dominique
Z
Jones,
Erica
N
Rogers,
Nayla
C
Kidd,
Sydney
Beache,
James
E
Rudd,
Camille
Ragin,
Maria
Jackson,
Norma
McFarlane-Anderson,
Marshall
Tulloch-Reid,
Seian
Morrison,
Guy
N
Brock,
Shirish
S
Barve,
Kevin
S
Kimbro
Hereditary Cancer in Clinical Practice 2012, 10 :16 (20 November 2012)
Abstract | Full text | PDF | PubMed
7.
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece
Chrissovaladis
Koumpis,
Constantine
Dimitrakakis,
Aris
Antsaklis,
Robert
Royer,
Shiyu
Zhang,
Steven
A
Narod,
Joanne
Kotsopoulos
Hereditary Cancer in Clinical Practice 2011, 9 :10 (15 November 2011)
Abstract | Full text | PDF | PubMed
8.
Case report: BRCA in the Ashkenazi population: are current testing guidelines too exclusive?
Katherine
H
Saunders,
Shivani
Nazareth,
Peter
I
Pressman
Hereditary Cancer in Clinical Practice 2011, 9 :3 (28 June 2011)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Saunders and colleagues report on a woman from the Ashkenazi Jewish population who was denied testing for BRCA1/2 mutations because no such mutation had been identified in her sister who was diagnosed with breast cancer at age 33. The woman therefore underwent direct-to-consumer DNA testing and discovered that she was a mutation carrier. This case demonstrates the need for clinicians to be aware of the higher prevalence of BRCA mutations in the Ashkenazi population. It also illustrates that individuals may choose to use direct-to-consumer DNA testing if testing in a clinical setting is denied to them.
9.
Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals' perspectives
Audrey
Ardern-Jones,
Regina
Kenen,
Elly
Lynch,
Rebecca
Doherty,
Rosalind
Eeles
Hereditary Cancer in Clinical Practice 2010, 8 :1 (12 January 2010)
Abstract | Full text | PDF | PubMed
